Tomycz Luke, Bansal Neil K, Hawley Catherine R, Goddard Tracy L, Ayad Michael J, Mericle Robert A
Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
Surg Neurol Int. 2011;2:134. doi: 10.4103/2152-7806.85607. Epub 2011 Sep 30.
Based on numerous reports citing high sensitivity and specificity of non-invasive imaging [e.g. computed tomography angiography (CTA) or magnetic resonance angiography (MRA)] in the detection of intracranial aneurysms, it has become increasingly difficult to justify the role of conventional angiography [digital subtraction angiography (DSA)] for diagnostic purposes. The current literature, however, largely fails to demonstrate the practical application of these technologies within the context of a "real-world" neurosurgical practice. We sought to determine the proportion of patients for whom the additional information gleaned from 3D rotational DSA (3DRA) led to a change in treatment.
We analyzed the medical records of the last 361 consecutive patients referred to a neurosurgeon at our institution for evaluation of "possible intracranial aneurysm" or subarachnoid hemorrhage (SAH). Only those who underwent non-invasive vascular imaging within 3 months prior to DSA were included in the study. For asymptomatic patients without a history of SAH, aneurysms less than 5 mm were followed conservatively. Treatment was advocated for patients with unruptured, non-cavernous aneurysms measuring 5 mm or larger and for any non-cavernous aneurysm in the setting of acute SAH.
For those who underwent CTA or MRA, the treatment plan was changed in 17/90 (18.9%) and 22/73 (30.1%), respectively, based on subsequent information gleaned from DSA. Several reasons exist for the change in the treatment plan, including size and location discrepancies (e.g. cavernous versus supraclinoid), or detection of a benign vascular variant rather than a true aneurysm.
In a "real-world" analysis of intracranial aneurysms, DSA continues to play an important role in determining the optimal management strategy.
基于大量报告称无创成像技术[如计算机断层血管造影(CTA)或磁共振血管造影(MRA)]在检测颅内动脉瘤方面具有高敏感性和特异性,传统血管造影术[数字减影血管造影(DSA)]用于诊断目的的作用越来越难以得到合理证明。然而,当前文献在很大程度上未能展示这些技术在“现实世界”神经外科实践中的实际应用。我们试图确定从三维旋转DSA(3DRA)获得的额外信息导致治疗方案改变的患者比例。
我们分析了连续361例转诊至我院神经外科医生处评估“可能的颅内动脉瘤”或蛛网膜下腔出血(SAH)患者的病历。仅纳入在DSA前3个月内接受过无创血管成像检查的患者。对于无SAH病史的无症状患者,直径小于5mm的动脉瘤采取保守观察。对于未破裂的、直径5mm或更大的非海绵窦段动脉瘤患者以及急性SAH情况下的任何非海绵窦段动脉瘤患者,建议进行治疗。
对于接受CTA或MRA检查的患者,基于随后从DSA获得的信息,治疗方案分别在17/90(18.9%)和22/73(30.1%)的患者中发生了改变。治疗方案改变存在多种原因,包括大小和位置差异(如海绵窦段与床突上段),或检测到良性血管变异而非真正的动脉瘤。
在对颅内动脉瘤的“现实世界”分析中,DSA在确定最佳治疗策略方面继续发挥重要作用。